摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(3-bromothiophen-2-yl)acrylic acid | 1310567-99-7

中文名称
——
中文别名
——
英文名称
(E)-3-(3-bromothiophen-2-yl)acrylic acid
英文别名
trans-3-(3-bromothiophen-2-yl)propenoic acid;3-(3-bromo-thien-2-yl)acrylic acid;3-(3-bromo-2-thienyl)acrylic acid;3-(3-Bromothiophen-2-yl)prop-2-enoic acid;(E)-3-(3-bromothiophen-2-yl)prop-2-enoic acid
(E)-3-(3-bromothiophen-2-yl)acrylic acid化学式
CAS
1310567-99-7
化学式
C7H5BrO2S
mdl
——
分子量
233.085
InChiKey
WSVBRXILDIUXOA-OWOJBTEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    349.8±27.0 °C(Predicted)
  • 密度:
    1.783±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Tetrazole amide derivatives of heterocyclic alkenyl acids and their use as antiallergic substances
    申请人:VALEAS S.p.A. INDUSTRIA CHIMICA E FARMACEUTICA
    公开号:EP0384450A1
    公开(公告)日:1990-08-29
    Tetrazole amide derivatives of heterocyclic alkenyl acids, of general formula (I): in which Y = NH, O or S when m = 1; Y = N when m = 2; m = 1 or 2; l = 0 or 4; R = H, C₁₋₄ alkyl, Cl, Br, CF₃, CH₂OCOCH₃, or OCH₂-Ph; R₁ = H, alkaline metal or alkaline earth metal; the double bond of the alkenyl chain being of trans or cis configuration and the possible benzene ring being unsubstituted or substituted. Said derivatives possess high antiallergic activity.
    杂环烯烃酸的四唑酰胺衍生物,一般式(I)如下:其中Y = NH、O或S,当m = 1 时;Y = N,当m = 2 时;m = 1 或 2;l = 0 或 4;R = H、C₁₋₄烷基、Cl、Br、CF₃、CH₂OCOCH₃或OCH₂-Ph;R₁ = H、碱金属或碱土金属;烯烃链的双键为顺式或反式构型,可能的苯环未取代或取代。这些衍生物具有很高的抗过敏活性。
  • Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones
    作者:Richard L. Jarvest、Ivan L. Pinto、Stephen M. Ashman、Christine E. Dabrowski、Annabellee V. Fernandez、L.John Jennings、Patrick Lavery、David G. Tew
    DOI:10.1016/s0960-894x(99)00004-9
    日期:1999.2
    Cinnamyl derivatives of thieno[2,3-d]oxazinones are mechanism-based inhibitors of the HSV-2, VZV and CMV herpes proteases which demonstrate nanomolar potency. Compounds 5 and 28 inhibit protease processing in HSV-2 infected cells with a selectivity index of at least 30. (C) 1999 Elsevier Science Ltd. Ail rights reserved.
  • Structure–activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A)
    作者:J.P.D. van Veldhoven、C.C. Blad、C.M. Artsen、C. Klopman、D.R. Wolfram、M.J. Abdelkadir、J.R. Lane、J. Brussee、A.P. IJzerman
    DOI:10.1016/j.bmcl.2010.11.091
    日期:2011.5
    Nicotinic acid (niacin) has been used for decades as an antidyslipidemic drug in man. Its main target is the hydroxy-carboxylic acid receptor HCA2 (GPR109A), a G protein-coupled receptor. Other acids and esters such as methyl fumarate also interact with the receptor, which constituted the basis for the current study. We synthesized a novel series of substituted propenoic acids, such as fumaric acid esters, fumaric acid amides and cinnamic acid derivatives, and determined their affinities for the HCA2 receptor. We observed a rather restricted binding pocket on the receptor with trans-cinnamic acid being the largest planar ligand in our series with appreciable affinity for the receptor. Molecular modeling and analysis of the structure-activity relationships in the series suggest a planar trans-propenoic acid pharmacophore with a maximum length of 8 angstrom and out-of-plane orientation of the larger substituents. (C) 2010 Elsevier Ltd. All rights reserved.
  • US5039684A
    申请人:——
    公开号:US5039684A
    公开(公告)日:1991-08-13
  • [EN] HETEROARYL INHIBITORS OF PLASMA KALLIKREIN<br/>[FR] INHIBITEURS HÉTÉROARYLE DE LA KALLICRÉINE PLASMATIQUE
    申请人:SHIRE HUMAN GENETIC THERAPIES
    公开号:WO2022197758A1
    公开(公告)日:2022-09-22
    The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    本发明提供了一种化合物及其组合物,可用作血浆卡利肌酶的抑制剂,并表现出相同的理想特性。
查看更多

同类化合物

试剂2,5-Dibromo-3,4-dihexylthiophene 苯-1,2,4-三羧酸-丙烷-1,2,3-三醇(1:1) 碘吡咯 癸氯-二茂铁 溴代二茂铁 溴-(3-溴-2-噻嗯基)镁 派瑞林D 派瑞林 F 二聚体 氯代二茂铁 曲洛酯 异噻唑,3-氯-5-甲基- 地茂酮 四碘噻吩 四溴噻吩 四溴吡咯 四溴-N-甲基吡咯 四氯噻吩 四氟噻吩 噻菌腈 噻美尼定. 噻吩,3-溴-4-(1-辛炔基)- 噻吩,2,5-二氯-3,4-二(氯甲基)- 喷贝特 咪唑烷,2-(4-溴-5-甲基-2-呋喃基)-1,3-二甲基- 叔丁基2-溴-4,6-二氢-5H-吡咯并[3,4-D]噻唑-5-羧酸酯 叔-丁基2-溴-5,6-二氢咪唑并[1,2-A]吡嗪-7(8H)-甲酸基酯 八氟联苯烯 八氟二苯并硒吩 二苯基氯化碘盐 二联苯碘硫酸盐 二氯对二甲苯二聚体 二氯[2-甲基-3(2H)-异噻唑酮-O]的钙合物 二氯-1,2-二硫环戊烯酮 二-(3-溴-1,2,4-噻二唑-5-基)-二硫醚 二(2-噻吩基)碘鎓 [四丁基铵][Δ-三(四氯-1,2-苯二醇酸根)磷酸盐(V)] [3-(4-氯-3,5-二甲基-1H-吡唑-1-基)丙基]胺 [3-(4-氯-1H-吡唑-1-基)-2-甲基丙基]胺 [2-(4-溴-吡唑-1-基)-乙基]-二甲胺 [1-(4-溴-3-甲基-1,2-噻唑-5-基)乙亚基氨基]硫脲 [1-(4-溴-1,2-噻唑-3-基)乙亚基氨基]硫脲 [1,1'-联苯]-2,2'-二基碘鎓 [(4-碘-1,2-噻唑-5-基)亚甲基氨基]硫脲 [(4-氯-1,2-噻唑-5-基)亚甲基氨基]硫脲 N-苄基-2-氯吡咯 N-Boc-2-氨基-3-溴噻吩 N-(2-氯-4-甲基-3-噻吩)-4,5-二氢-1H-咪唑-2-胺盐酸盐 N-(2,5-二溴-1H-吡咯-1-基)-氨基甲酸叔丁酯 N,N-二甲基-5-碘-1H-吡唑-1-磺酰胺 N,N-二甲基-2-(3,4,5-三溴吡唑-1-基)丙酰胺